에임드바이오
₩26,500
▼ 1200.00
(-4.33%)
Volume: 412,811
· 2026-06-05
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
25
- 21d momentum -43.2%
- RSI 24 oversold
🎯
Pullback
73
- RSI 24 near lows
- Near lower Bollinger band
- -28.5% vs 20MA
💎
Value
46
- ROE -1.1%
- Op. margin -46.6%
- -49% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)23.7
MACD—
MA trendMixed
ATR12.61%
21d mom.-43.2%
63d mom.—
vs 20MA-28.5%
RVOL(20)1.42×
52w low · 25,750
52w high · 51,700
-48.7% from 52-week high
20d support 25,750
· resistance 47,300
Computed live from daily OHLCV · as of 2026-06-05
🏦 Fundamentals
ROE-1.1%
Op. margin-46.6%
Net margin-23.7%
FY2026
| Year | Revenue | Op. income | Op. margin |
|---|---|---|---|
| 2025 | 0.0T | 0.0T | 43.9% |
| 2026 | 0.0T | -0.0T | -46.6% |
From DART financial statements (KRW). Annual (or latest reported quarter).
⚖️ AI Bull vs Bear
14d momentum -35.37%, daily vol 5.30%. 에임드바이오 sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.
🏦 Investor Flow
Foreign
+4억
Institution
-2억
Retail
-2억
| Date | Foreign | Inst. | Retail |
|---|---|---|---|
| 09-23 | +4 | -2 | -2 |
| 09-22 | +6 | -6 | +0 |
| 09-21 | +5 | -2 | -3 |
| 09-18 | -4 | -0 | +4 |
| 09-17 | -2 | -2 | +3 |
Net buy/sell in ₩100M (억). Positive = net buying.